Mineralys Stock Based Compensation from 2010 to 2025

MLYS Stock   10.36  0.44  4.44%   
Mineralys Therapeutics, Stock Based Compensation yearly trend continues to be comparatively stable with very little volatility. Stock Based Compensation is likely to outpace its year average in 2025. Stock Based Compensation is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. View All Fundamentals
 
Stock Based Compensation  
First Reported
2010-12-31
Previous Quarter
11.3 M
Current Value
11.9 M
Quarterly Volatility
M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Mineralys Therapeutics, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Mineralys Therapeutics,'s main balance sheet or income statement drivers, such as Net Interest Income of 15.3 M, Depreciation And Amortization of 143.6 K or Interest Expense of 2 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.28. Mineralys financial statements analysis is a perfect complement when working with Mineralys Therapeutics, Valuation or Volatility modules.
  
Check out the analysis of Mineralys Therapeutics, Correlation against competitors.

Latest Mineralys Therapeutics,'s Stock Based Compensation Growth Pattern

Below is the plot of the Stock Based Compensation of Mineralys Therapeutics, Common over the last few years. It is compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders. Mineralys Therapeutics,'s Stock Based Compensation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Mineralys Therapeutics,'s overall financial position and show how it may be relating to other accounts over time.
Stock Based Compensation10 Years Trend
Slightly volatile
   Stock Based Compensation   
       Timeline  

Mineralys Stock Based Compensation Regression Statistics

Arithmetic Mean1,802,800
Geometric Mean10,585
Coefficient Of Variation223.72
Mean Deviation2,861,300
Median1,000.00
Standard Deviation4,033,172
Sample Variance16.3T
Range11.9M
R-Value0.67
Mean Square Error9.6T
R-Squared0.45
Significance0
Slope567,897
Total Sum of Squares244T

Mineralys Stock Based Compensation History

202511.9 M
202411.3 M
20235.1 M
2022455 K
202180 K

Other Fundumenentals of Mineralys Therapeutics,

Mineralys Therapeutics, Stock Based Compensation component correlations

About Mineralys Therapeutics, Financial Statements

Mineralys Therapeutics, shareholders use historical fundamental indicators, such as Stock Based Compensation, to determine how well the company is positioned to perform in the future. Although Mineralys Therapeutics, investors may analyze each financial statement separately, they are all interrelated. The changes in Mineralys Therapeutics,'s assets and liabilities, for example, are also reflected in the revenues and expenses on on Mineralys Therapeutics,'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Stock Based Compensation11.3 M11.9 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Mineralys Stock Analysis

When running Mineralys Therapeutics,'s price analysis, check to measure Mineralys Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mineralys Therapeutics, is operating at the current time. Most of Mineralys Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Mineralys Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mineralys Therapeutics,'s price. Additionally, you may evaluate how the addition of Mineralys Therapeutics, to your portfolios can decrease your overall portfolio volatility.